Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2018

01-11-2018 | Stanford Multidisciplinary Seminars

Perianal Extramammary Paget’s Disease: More Than Meets the Eye

Authors: Jeff Choi, Allison Zemek, Gordon K. Lee, Cindy Kin

Published in: Digestive Diseases and Sciences | Issue 11/2018

Login to get access

Excerpt

A 75-year-old man was initially evaluated for a 1-year history of perianal pruritus that was refractory to multiple topical therapies. He had a sharply demarcated, erythematous and scaly rash involving the left perianal skin, originating from the left hemi-circumference of the anal verge and extending anteriorly, laterally and posteriorly to involve a 6 cm × 4 cm area of skin (Fig. 1). A punch biopsy of the lesion confirmed extramammary Paget’s disease (EMPD). Immunostaining of the biopsy was positive for cytokeratin (CK)7 and GATA3, weakly positive for cytokeratin 20, and negative for CDX2 and prostate-specific antigen (PSA), all consistent with likely primary EMPD. Patient’s past history was notable for coronary artery disease and prostate cancer, for which he had undergone prostatectomy. His recent serum PSA had been unremarkable at 0.02 ng/mL. PSA immunostaining of the punch biopsy was negative, as was urine cytology, excluding underlying urothelial intraepithelial neoplasia. Further evaluation to exclude an underlying malignancy included computed tomography (CT) of the abdomen and pelvis, which was unremarkable. Colonoscopy from several months prior to initial presentation was likewise negative.
Literature
1.
go back to reference Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef
2.
go back to reference Mengun B, Zheng-Qiang W, Tasleem MM. Extramammary Paget’s disease of the perianal region: a review of the literature emphasizing management. Dermatol Surg. 2013;39:69–75.CrossRef Mengun B, Zheng-Qiang W, Tasleem MM. Extramammary Paget’s disease of the perianal region: a review of the literature emphasizing management. Dermatol Surg. 2013;39:69–75.CrossRef
3.
go back to reference Tanaka VD, Sanches JA, Toresan L, Niwa AB, Festa Neto C. Mammary and extramammary Paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics. 2009;64:599–606.CrossRef Tanaka VD, Sanches JA, Toresan L, Niwa AB, Festa Neto C. Mammary and extramammary Paget’s disease: a study of 14 cases and the associated therapeutic difficulties. Clinics. 2009;64:599–606.CrossRef
4.
go back to reference Wang X, Yang W, Yang J. Extramammary Paget’s disease with the appearance of a nodule: a case report. BMC Cancer. 2010;10:405.CrossRef Wang X, Yang W, Yang J. Extramammary Paget’s disease with the appearance of a nodule: a case report. BMC Cancer. 2010;10:405.CrossRef
5.
go back to reference Perrotto J, Abbott JJ, Ceilley RI, Ahmed I. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease. Am J Dermatopathol. 2010;32:137.CrossRef Perrotto J, Abbott JJ, Ceilley RI, Ahmed I. The role of immunohistochemistry in discriminating primary from secondary extramammary Paget disease. Am J Dermatopathol. 2010;32:137.CrossRef
6.
go back to reference Chanda JJ. Extramammary Paget’s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol. 1985;13:1009–1014.CrossRef Chanda JJ. Extramammary Paget’s disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol. 1985;13:1009–1014.CrossRef
7.
go back to reference Zhu Y, Ye DW, Yao XD, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget’s disease. Br J Dermatol. 2009;161:577–582.CrossRef Zhu Y, Ye DW, Yao XD, et al. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget’s disease. Br J Dermatol. 2009;161:577–582.CrossRef
8.
go back to reference Tsutsumida A, Yamamoto Y, Minakawa H, et al. Indications for lymph node dissection in the treatment of extramammary Paget’s disease. Dermatol Surg. 2003;29:21–24.PubMed Tsutsumida A, Yamamoto Y, Minakawa H, et al. Indications for lymph node dissection in the treatment of extramammary Paget’s disease. Dermatol Surg. 2003;29:21–24.PubMed
9.
go back to reference Nakamura Y, Fujisawa Y, Ishikawa M, et al. Usefulness of sentinel lymph node biopsy for extramammary Paget disease. Br J Dermatol. 2012;167:954–956.CrossRef Nakamura Y, Fujisawa Y, Ishikawa M, et al. Usefulness of sentinel lymph node biopsy for extramammary Paget disease. Br J Dermatol. 2012;167:954–956.CrossRef
10.
go back to reference Fujisawa Y, Yoshino K, Kiyohara Y, et al. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget’s disease: multi-center, retrospective study of 151 patients. J Dermatol Sci.. 2015;79:38–42.CrossRef Fujisawa Y, Yoshino K, Kiyohara Y, et al. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget’s disease: multi-center, retrospective study of 151 patients. J Dermatol Sci.. 2015;79:38–42.CrossRef
12.
go back to reference Ito Y, Igawa S, Ohishi Y, et al. Prognostic indicators in 35 patients with extramammary Paget’s disease. Dermatol Surg. 2012;38:1938–1944.CrossRef Ito Y, Igawa S, Ohishi Y, et al. Prognostic indicators in 35 patients with extramammary Paget’s disease. Dermatol Surg. 2012;38:1938–1944.CrossRef
13.
go back to reference Hatta N, Yamada M, Hirano T, et al. Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008;158:313–318.PubMed Hatta N, Yamada M, Hirano T, et al. Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol. 2008;158:313–318.PubMed
14.
go back to reference Karam A, Dorigo O. Treatment outcomes in a large cohort of patients with invasive extramammary Paget’s disease. Gynecol Oncol. 2012;125:346–351.CrossRef Karam A, Dorigo O. Treatment outcomes in a large cohort of patients with invasive extramammary Paget’s disease. Gynecol Oncol. 2012;125:346–351.CrossRef
15.
go back to reference Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget’s disease. J Dermatol Sci. 2008;50:177–184.CrossRef Aoyagi S, Akiyama M, Shimizu H. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget’s disease. J Dermatol Sci. 2008;50:177–184.CrossRef
16.
go back to reference Hatta N, Morita R, Yamada M, et al. Sentinel lymph node biopsy in patients with extramammary Paget’s disease. Dermatol Surg. 2004;30:1329–1334.PubMed Hatta N, Morita R, Yamada M, et al. Sentinel lymph node biopsy in patients with extramammary Paget’s disease. Dermatol Surg. 2004;30:1329–1334.PubMed
17.
go back to reference Hata H, Abe R, Hoshina D, et al. MUC5AC expression correlates with invasiveness and progression of extramammary Paget’s disease. J Eur Acad Dermatol Venereol. 2014;28:727–732.CrossRef Hata H, Abe R, Hoshina D, et al. MUC5AC expression correlates with invasiveness and progression of extramammary Paget’s disease. J Eur Acad Dermatol Venereol. 2014;28:727–732.CrossRef
18.
go back to reference Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef Lam C, Funaro D. Extramammary Paget’s disease: summary of current knowledge. Dermatol Clin. 2010;28:807–826.CrossRef
19.
go back to reference Perez DR, Trakarnsanga A, Shia J, et al. Management and outcome of perianal Paget’s disease. Dise Colon Rectum. 2014;57:747–751.CrossRef Perez DR, Trakarnsanga A, Shia J, et al. Management and outcome of perianal Paget’s disease. Dise Colon Rectum. 2014;57:747–751.CrossRef
20.
go back to reference Minicozzi A, Borzellino G, Momo R, Steccanella F, et al. Perianal Paget’s disease: presentation of six cases and literature review. Int J Colorectal Dis. 2010;25:1–7.CrossRef Minicozzi A, Borzellino G, Momo R, Steccanella F, et al. Perianal Paget’s disease: presentation of six cases and literature review. Int J Colorectal Dis. 2010;25:1–7.CrossRef
21.
go back to reference Hendi A, Brodland DG, Zitelli JA. Extramammary Paget disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef Hendi A, Brodland DG, Zitelli JA. Extramammary Paget disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef
22.
go back to reference Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC, Milsom JW. Long-term outcome of patients with perianal Paget’s disease. Ann Surg Oncol. 1997;4:475–480.CrossRef Marchesa P, Fazio VW, Oliart S, Goldblum JR, Lavery IC, Milsom JW. Long-term outcome of patients with perianal Paget’s disease. Ann Surg Oncol. 1997;4:475–480.CrossRef
23.
go back to reference Hendi A, Brodland DG, Zitelli JA. Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef Hendi A, Brodland DG, Zitelli JA. Extramammary Paget’s disease: surgical treatment with Mohs micrographic surgery. J Am Acad Dermatol. 2004;51:767–773.CrossRef
24.
go back to reference Housel JP, Izikson L, Zeitouni NC. Noninvasive extramammary Paget’s disease treated with photodynamic therapy: case series from the Roswell park cancer institute. Dermatol Surg. 2010;36:1718–1724.CrossRef Housel JP, Izikson L, Zeitouni NC. Noninvasive extramammary Paget’s disease treated with photodynamic therapy: case series from the Roswell park cancer institute. Dermatol Surg. 2010;36:1718–1724.CrossRef
25.
go back to reference Shieh S, Dee AS, Cheney RT, Frawley NP, et al. Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol. 2002;146:1000–1005.CrossRef Shieh S, Dee AS, Cheney RT, Frawley NP, et al. Photodynamic therapy for the treatment of extramammary Paget’s disease. Br J Dermatol. 2002;146:1000–1005.CrossRef
26.
go back to reference Vereecken P, Awada A, Ghanem G, Marques da Costa C, et al. A therapeutic approach to perianal extramammary Paget’s disease: topical imiquimod can be useful to prevent or defer surgery. Med Sci Monit. 2007;13:75–77. Vereecken P, Awada A, Ghanem G, Marques da Costa C, et al. A therapeutic approach to perianal extramammary Paget’s disease: topical imiquimod can be useful to prevent or defer surgery. Med Sci Monit. 2007;13:75–77.
27.
go back to reference Zampognoa JC, Flowers FP, Roth WI, Hassenein AM. Treatment of primary limited cutaneous extramammary Paget’s disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2004;4:229–235. Zampognoa JC, Flowers FP, Roth WI, Hassenein AM. Treatment of primary limited cutaneous extramammary Paget’s disease with topical imiquimod monotherapy: two case reports. J Am Acad Dermatol. 2004;4:229–235.
28.
go back to reference Hata M, Omura M, Koike I, Wada H, et al. Role of radiotherapy as curative treatment of extramammary Paget’s disease. Int J Radiat Oncol Biol Phys. 2011;80:47–54.CrossRef Hata M, Omura M, Koike I, Wada H, et al. Role of radiotherapy as curative treatment of extramammary Paget’s disease. Int J Radiat Oncol Biol Phys. 2011;80:47–54.CrossRef
29.
go back to reference Dilmé-Carreras E, Iglesias-Sancho M, Márquez-Balbás G, Sola-Ortigosa J, Umbert-Millet P, et al. Radiotherapy for extramammary Paget disease of the anogenital region. J Am Acad Dermatol. 2011;65:192–194.CrossRef Dilmé-Carreras E, Iglesias-Sancho M, Márquez-Balbás G, Sola-Ortigosa J, Umbert-Millet P, et al. Radiotherapy for extramammary Paget disease of the anogenital region. J Am Acad Dermatol. 2011;65:192–194.CrossRef
30.
go back to reference Yanagi T, Kato N, Yamane N, Osawa R, et al. Radiotherapy for extramammary Paget’s disease: histopathological findings after radiotherapy. Clin Exp Dermatol. 2007;32:506–508.CrossRef Yanagi T, Kato N, Yamane N, Osawa R, et al. Radiotherapy for extramammary Paget’s disease: histopathological findings after radiotherapy. Clin Exp Dermatol. 2007;32:506–508.CrossRef
31.
go back to reference Kariya K, Tsuji T, Schwartz RA. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget’s disease. Dermatol Surg. 2004;30:341–344.PubMed Kariya K, Tsuji T, Schwartz RA. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget’s disease. Dermatol Surg. 2004;30:341–344.PubMed
32.
go back to reference Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T. Successful treatment of metastatic extramammary Paget’s disease with S-1 and docetaxel combination chemotherapy. J Dermatol. 2011;38:996–998.CrossRef Matsushita S, Yonekura K, Mera K, Kawai K, Kanekura T. Successful treatment of metastatic extramammary Paget’s disease with S-1 and docetaxel combination chemotherapy. J Dermatol. 2011;38:996–998.CrossRef
33.
go back to reference Takahagi S, Noda H, Kamegashira A, Madokoro N, et al. Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009;36:457–461.CrossRef Takahagi S, Noda H, Kamegashira A, Madokoro N, et al. Metastatic extramammary Paget’s disease treated with paclitaxel and trastuzumab combination chemotherapy. J Dermatol. 2009;36:457–461.CrossRef
Metadata
Title
Perianal Extramammary Paget’s Disease: More Than Meets the Eye
Authors
Jeff Choi
Allison Zemek
Gordon K. Lee
Cindy Kin
Publication date
01-11-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5089-1

Other articles of this Issue 11/2018

Digestive Diseases and Sciences 11/2018 Go to the issue